Pain is a common and debilitating symptom of cancer. Cancer-related pain can occur at any point along the continuum from diagnosis to treatment to survivorship1. A systematic review published in 2016 estimated the prevalence of cancer pain to be 55% in those undergoing antineoplastic treatment, 66.4% in advanced cancer, and 39.3% in the post-treatment population. Thirty-eight percent of cancer patients in this pooled analysis experienced moderate to severe pain2.
CITATION STYLE
Glasser, M., Chen, J., Alzarah, M., & Wallace, M. (2021). Non-opioid Analgesics and Emerging Therapies. In Cancer Treatment and Research (Vol. 182, pp. 125–142). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/978-3-030-81526-4_9
Mendeley helps you to discover research relevant for your work.